HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Possible involvement of opioidergic systems in the antinociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice.

Abstract
The involvement of opioid receptor activation in the antinociceptive effect of either fluvoxamine, a selective serotonin reuptake inhibitor, or serotonin (5-HT) on thermal hyperalgesia and mechanical allodynia in a model of neuropathic pain in mice induced by sciatic nerve ligation was examined. The experiments were conducted 2 or 6 weeks after unilateral sciatic nerve ligation. Ipsilateral thermal hyperalgesia and mechanical allodynia were observed both 2 and 6 weeks after sciatic nerve ligation. Neither s.c. fluvoxamine nor i.t. 5-HT affected sciatic nerve ligation-induced thermal hyperalgesia or mechanical allodynia in mice 2 weeks after sciatic nerve ligation. However, the same dose of either fluvoxamine or 5-HT significantly reduced mechanical allodynia but not thermal hyperalgesia in sciatic nerve ligated mice 6 weeks after surgery. The antinociceptive effect of fluvoxamine on sciatic nerve ligation-induced mechanical allodynia in mice 6 weeks after surgery was completely abolished by pretreatment with either naloxone, a nonselective opioid receptor antagonist, or beta-funaltrexamine, a selective mu-opioid receptor antagonist. Furthermore, pretreatment with naltrindole, a selective delta-opioid receptor antagonist, partially but significantly inhibited the antinociceptive effect of fluvoxamine in sciatic nerve ligated mice at the 6th postoperative week. The antinociceptive effect induced by i.t. 5-HT was also completely antagonized by either naloxone or beta-funaltrexamine, and partially inhibited by naltrindole. However, pretreatment with nor-binaltorphimine, a selective kappa-opioid receptor antagonist, had no effect against either s.c. fluvoxamine- or i.t. 5-HT-induced antinociception. These results suggest that the antinociceptive effect of s.c. fluvoxamine or i.t. 5-HT in the chronic state of sciatic nerve ligation-induced neuropathic pain may be related to opioidergic activity, mainly through the activation of spinal mu- and delta-opioid receptors.
AuthorsChihiro Nozaki, Junzo Kamei
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 552 Issue 1-3 Pg. 99-104 (Dec 15 2006) ISSN: 0014-2999 [Print] Netherlands
PMID17056034 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics
  • Narcotic Antagonists
  • Receptors, Opioid
  • Serotonin Agents
  • Serotonin Antagonists
  • Serotonin Uptake Inhibitors
  • Serotonin
  • Naloxone
  • Ondansetron
  • Ketanserin
  • Fluvoxamine
Topics
  • Analgesics (pharmacology)
  • Animals
  • Dose-Response Relationship, Drug
  • Fluvoxamine (pharmacology)
  • Hyperalgesia (physiopathology, prevention & control)
  • Injections, Spinal
  • Ketanserin (pharmacology)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Naloxone (pharmacology)
  • Narcotic Antagonists
  • Neuralgia (physiopathology, prevention & control)
  • Ondansetron (pharmacology)
  • Receptors, Opioid (physiology)
  • Sciatic Nerve (injuries, physiopathology, surgery)
  • Serotonin (administration & dosage, pharmacology)
  • Serotonin Agents (pharmacology)
  • Serotonin Antagonists (pharmacology)
  • Selective Serotonin Reuptake Inhibitors (pharmacology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: